Form D Worth Watching: Metacrine $37.77 million Fundraising. Ken Song Submitted Nov 2 Form D

Pharmaceuticals Metacrine, Inc. - Ken Song

Metacrine Financing

Metacrine, Inc., Corporation just filed form D because of $37.77 million equity financing. The date of first sale was 2015-01-30. Metacrine was able to finance itself with $37.77 million. That is 100.00% of the financing offer. The total private financing amount was $37.77 million. The financing form was filed on 2016-11-02. The reason for the financing was: Total Offering amount includes $338,456.61 of securities issued upon conversion of indebtedness..

Metacrine is based in California. The filler’s business is Pharmaceuticals. The D form was submitted by Ken Song President and CEO. The company was incorporated in 2014. The filler’s address is: 12780 El Camino Real, #301, San Diego, Ca, California, 92130. Ken Song is the related person in the form and it has address: 12780 El Camino Real, Suite #301, San Diego, Ca, California, 92130. Link to Metacrine Filing: 000163437916000003.

Analysis of Metacrine Offering

On average, startups in the Pharmaceuticals sector, sell 60.90% of the total offering size. Metacrine sold 100.00% of the offering. Could this mean that the trust in Metacrine is high? The average investment floor size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 6,692.56% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this financing is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Metacrine Also

The Form D signed by Ken Song might help Metacrine, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment